Company Update (NYSE:JNJ): Johnson & Johnson Issues Call for Innovative Ideas to Reduce HIV Infections in Sub-Saharan Africa

[PR Newswire] – NEW BRUNSWICK, N.J., Feb. 17, 2016 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today issued a call for innovative ideas as part of the DREAMS Innovation Challenge, which is supported by the U.S. President’s … Read more on this. Johnson & Johnson (JNJ) , with a current market cap of $283.07B, began trading this morning at $102.75. Looking at today’s market, JNJ one day range is $102.24 to $103.24 with the price of the stock fluctuating between $81.79 to $105.49 over the last 52 weeks. JNJ shares are currently priced at 15.60x this year’s forecasted earnings, which makes them relatively expensive compared to the industry ’s -4.96x earnings multiple. And for dividend hunters, the company pays shareholders $3.00 per share annually in dividends, yielding 2.95%. Consensus earnings for the current quarter by the 18 sell-side analysts covering the stock is an estimate of $1.66 per share, which would be $0.10 better than the year-ago quarter and a $0.03 sequential increase. In looking at the bigger picture, the full-year EPS estimate of $6.52 would be a $0.32 improvement when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $17.47 Billion. If reported, that would be a 0.58% increase over the year-ago quarter. More recently, Barclays downgraded JNJ from Overweight to Equal Weight (Jan 10, 2014). Previously, RBC Capital Mkts upgraded JNJ from Sector Perform to Outperform. The average price target for JNJ shares by the analysts covering it is $109.24, which is 6.32% above where the stock opened. See more in (NYSE:JNJ) Similar Articles: Market Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Joins First Industry-wide Call for New Collective Action to Address Antimicrobial Resistance Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Participate in the 24th Annual Credit Suisse Health Care Conference Company Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2015